Evaluation of Breast Cancer Subtypes Based on ER PR and Her2 Expression: A Clinicopathologic Study of Hormone Receptor Status (ER PR HER2-Neu) in Breast Cancer. Faridpur Med Coll J 2020, 14 (1), 8-12. https://doi.org/10.3329/fmcj.v14i1.46158.